Total Payments
$1,757
2024 Payments
$308.42
Companies
15
Transactions
95
Medicare Patients
13,276
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$1,736 (98.8%)
Education$21.28 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,736 | 91 | 98.8% |
| Education | $21.28 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $353.98 | 6 | $0 (2023) |
| PFIZER INC. | $276.25 | 39 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $251.36 | 21 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $219.55 | 7 | $0 (2024) |
| Ancora Heart, Inc. | $166.43 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $81.15 | 1 | $0 (2022) |
| Kestra Medical Technology Services, Inc. | $79.60 | 3 | $0 (2024) |
| Tactile Systems Technology Inc | $75.41 | 4 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $55.83 | 3 | $0 (2023) |
| Akcea Therapeutics, Inc. | $52.33 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $308.42 | 7 | Ancora Heart, Inc. ($166.43) |
| 2023 | $299.85 | 4 | Abbott Laboratories ($154.15) |
| 2022 | $255.74 | 4 | Abbott Laboratories ($162.76) |
| 2021 | $189.87 | 21 | PFIZER INC. ($132.46) |
| 2020 | $11.72 | 1 | SANOFI-AVENTIS U.S. LLC ($11.72) |
| 2019 | $386.97 | 40 | Janssen Pharmaceuticals, Inc ($156.14) |
| 2018 | $171.49 | 10 | Janssen Pharmaceuticals, Inc ($59.62) |
| 2017 | $132.73 | 8 | Lantheus Medical Imaging, Inc. ($35.14) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $27.95 | General |
| Category: Cardiology | ||||||
| 03/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: Cardiology | ||||||
| 02/28/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $166.43 | General |
| Category: Cardiovascular | ||||||
| 02/09/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $32.09 | General |
| Category: Cardiology | ||||||
| 11/02/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Heart Failure | ||||||
| 09/26/2023 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: CONTRAST AGENT | ||||||
| 06/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $129.89 | General |
| Category: Heart Failure | ||||||
| 11/29/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: WATCHMAN_IC | ||||||
| 06/12/2022 | Abbott Laboratories | AMPLATZER (Device) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Structural Heart | ||||||
| 04/02/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $81.15 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/21/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $149.77 | General |
| Category: Heart Failure | ||||||
| 12/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Cardiovascular & Me | ||||||
| 11/19/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/20/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Heart Failure | ||||||
| 08/24/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,601 | 4,676 | $1.4M | $333,529 |
| 2022 | 23 | 2,968 | 4,012 | $1.3M | $348,898 |
| 2021 | 31 | 3,330 | 4,401 | $1.4M | $386,857 |
| 2020 | 35 | 3,377 | 4,242 | $1.2M | $319,397 |
Total Patients
13,276
Total Services
17,331
Medicare Billing
$1.4M
Procedure Codes
140
All Medicare Procedures & Services
140 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 520 | 658 | $170,422 | $58,536 | 34.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 280 | 382 | $139,812 | $53,479 | 38.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 357 | 362 | $304,442 | $51,902 | 17.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 122 | 122 | $196,054 | $43,650 | 22.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 128 | 255 | $125,715 | $23,670 | 18.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 116 | 194 | $48,112 | $18,693 | 38.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 77 | 312 | $28,704 | $13,192 | 46.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 71 | $31,027 | $9,783 | 31.5% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 110 | 221 | $23,426 | $7,461 | 31.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 132 | 133 | $45,619 | $6,518 | 14.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 410 | 440 | $36,080 | $4,816 | 13.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $11,616 | $4,417 | 38.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 67 | 72 | $38,520 | $4,310 | 11.2% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 48 | 48 | $19,584 | $3,550 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $8,370 | $3,175 | 37.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 61 | 61 | $15,616 | $3,039 | 19.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 53 | 53 | $18,550 | $2,908 | 15.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 36 | 36 | $7,056 | $2,119 | 30.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 225 | 325 | $10,075 | $2,108 | 20.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 86 | 93 | $18,321 | $2,037 | 11.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 66 | 95 | $14,820 | $1,837 | 12.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 146 | 219 | $4,818 | $1,823 | 37.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 28 | $4,704 | $1,757 | 37.3% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 103 | 108 | $15,876 | $1,395 | 8.8% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 14 | 15 | $3,420 | $1,061 | 31.0% |
About Dr. Dave Chua, MD
Dr. Dave Chua, MD is a Cardiovascular Disease healthcare provider based in Aurora, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508807280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dave Chua, MD has received a total of $1,757 in payments from pharmaceutical and medical device companies, with $308.42 received in 2024. These payments were reported across 95 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,736).
As a Medicare-enrolled provider, Chua has provided services to 13,276 Medicare beneficiaries, totaling 17,331 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 140 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Aurora, IL
- Active Since 06/10/2006
- Last Updated 11/22/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1508807280
Products in Payments
- CARDIOMEMS (Device) $303.92
- XARELTO (Drug) $251.36
- ELIQUIS (Drug) $226.74
- AccuCinch (Device) $166.43
- FARXIGA (Drug) $162.03
- EVKEEZA (Biological) $81.15
- Assure WCD (Device) $79.60
- FLEXITOUCH (Device) $75.41
- TEGSEDI (Drug) $52.33
- VYNDAQEL (Drug) $48.08
- BRILINTA (Drug) $44.86
- CHANTIX (Drug) $40.53
- CardioMEMS HF System (Device) $37.07
- Definity (Drug) $35.14
- MULTAQ (Drug) $32.42
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $25.37
- VALCHLOR MECHLORETHAMINE (Drug) $22.05
- DEFINITY (Drug) $20.69
- GENERAL THERAPIES (Device) $14.13
- AMPLATZER (Device) $12.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Aurora
Dr. Marc Bonaca, M.d, M.D
Cardiovascular Disease — Payments: $929,379
Cardiovascular Disease $929,379
Dr. Gareth Morgan, M.d, M.D
Cardiovascular Disease — Payments: $490,082
Cardiovascular Disease $490,082
Christopher Porterfield, Md Facc, MD FACC
Cardiovascular Disease — Payments: $252,156
Cardiovascular Disease $252,156
Jamaluddin Moloo, Md, MD
Cardiovascular Disease — Payments: $183,878
Cardiovascular Disease $183,878
Dr. Gregory Schwartz, Md Phd, MD PHD
Cardiovascular Disease — Payments: $116,337
Cardiovascular Disease $116,337
Edward Gill, Md, MD
Cardiovascular Disease — Payments: $109,839
Cardiovascular Disease $109,839